Genmab — Januar 2021
-
-
Ja hvor langt over $5 mia kommer dara i år..... så er der bare lige den der dollar der koster dyrt
Den er nede med små 15% fra toppen og spås et fald op mod yderligere 10%. Så måske en snit kurs i forhold til kursikring omkring det nuværende niveau -
God morgen.
-
-
this approval was very fast, specially if you consider the pandemic... 'The FDA approved this application 7 weeks ahead of the FDA goal date.' https://www.fda.gov/drugs/drug-approvals-and-databases/fda-grants-accelerated-approval-darzalex-faspro-newly-diagnosed-light-chain-amyloidosis
-
Ja, der er fart på:
Purpose of the RTOR Pilot
The Oncology Center of Excellence Real-Time Oncology Review (RTOR) pilot program aims to explore a more efficient review process to ensure that safe and effective treatments are available to patients as early as possible, while maintaining and improving review quality and balancing the review team’s workload through data and analysis standardization, and early iterative engagement with the applicant. -
ØU i dag: "Genmab går mod nye højder i det nye år. Der er linet op til et kapløb mellem Genmab og Roche indenfor de bi-specifikke antistof-fer i NHL. Efter lidt konsolidering omkring det nuværende kursleje virker aktien nu klar til at bevæge sig op i nye højder i det nye år". ...
-
Nyheden fra i går aftes er i sagens natur ikke med i David Myginds artikel.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind